ONCY Wutah bathi saben saham ing taun lumaku Oncolytics

Oncolytics Biotech Inc. relies on diversified manufacturing capacities in the US and Canada. This annual EPS growth chart visualizes profit dynamics, where -19.70 indicates the value of this parameter. Anticipation of Phase II trial data is driving quotes higher, yet capital shortages and regulatory uncertainty create significant financial threats for shareholders.

Wutah bathi resik saben saham ing taun iki oncolyticsbiotech.com (ONCY): kanggo periode 04.07.2022 - 14.11.2026

Rincian analitis lan laporan data perusahaan oncolyticsbiotech.com (ONCY)

- rega saiki lan proyeksi nilai saham:

Bagan kutipan Oncolytics|ONCY - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar Oncolytics Biotech|ONCY - Nilai Perusahaan

- indikator kapitalisasi buku:

Nilai Buku saben Saham Oncolytics Biotech|ONCY - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku oncolyticsbiotech.com|ONCY - Total Aset Perusahaan

- indikator beban utang lan likuiditas:

Utang Agregat marang Ekuitas Oncolytics Biotech Inc.|ONCY - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Oncolytics|ONCY - Utang perusahaan|Rasio utang marang aset resik Oncolytics Biotech Inc.|ONCY - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Oncolytics Biotech|Koefisien jangkoan perantara oncolyticsbiotech.com

- rincian bathi lan kelipatan pasar:

ONCY - Bathi resik perusahaan|Bathi resik sing dikarepake Oncolytics Biotech Inc.|ONCY - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Oncolytics Biotech, Inc.|ONCY - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Oncolytics Biotech Inc.|ONCY - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Oncolytics Biotech|ONCY - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan oncolyticsbiotech.com|ONCY - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun ngarep Oncolytics Biotech Inc.

- statistik dodolan lan pendapatan perusahaan:

ONCY - Dodolan perusahaan|Prakiraan volume pendapatan perusahaan Oncolytics Biotech, Inc.|ONCY - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake Oncolytics Biotech

Analisis dhasar perusahaan:oncolyticsbiotech.com (ONCY)

To minimize fundamental risks, investors select assets with sustainable earnings per share dynamics, where the year-over-year percentage change in EPS reflects margin efficiency and the impact of share buybacks. In the case of Oncolytics Biotech Inc. (ONCY), whose success depends on Pelareorep platform approvals and partnerships with big pharma, current annual EPS growth serves as an indicator of the financial viability of the entire biotech ecosystem.

Pesaing utama

Dinamika bathi saben saham ing taun lumaku GERN (Geron Bio)|Wutah bathi saben saham ing taun lumaku Nanobiotix S.A.|Wutah bathi saben saham ing taun lumaku BCYC|Wutah bathi ing taun lumaku CTMX|Wutah bathi ing taun lumaku Perspective Therapeutics Inc (CATX)|Genelux - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku MOLN (Molecular Partners)|Lisata Therapeutics - Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku MBRX|galeratx.com (GRTX) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Molecular Templates Inc (MTEM)